Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with <i>EGFR</i> MutationsSatoshi Morita, Toshihiro Nukiwa, Kunihiko Kobayashi et al.|Clinical Cancer Research|2009Cited by 189
Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanismsNoriko Yanagitani, Makoto Nishio|Cancer Science|2020Cited by 47